Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL6ST | P40189 | 5/20 | 0.45 |
| ▸ | IDH1 | O75874 | 12/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15515367 | 0.93 | IL6ST (0.48) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL15506109 | 0.93 | IL6ST (0.48) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL23162452 | 0.93 | IL6ST (0.48) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL3955785 | 0.81 | IL6ST (0.49) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL3948400 | 0.81 | IL6ST (0.49) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL3948407 | 0.81 | IL6ST (0.49) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL3955251 | 0.81 | IL6ST (0.49) | IL6STIDH1STAT3PIK3CD | |
| SCHEMBL9580353 | 0.81 | POLB (0.55) | IDH1 | |
| SCHEMBL17694469 | 0.79 | PPARA (0.42) | IL6STIDH1 | |
| SCHEMBL17694474 | 0.79 | IL6ST (0.42) | IL6STIDH1STAT3PIK3CDP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160108016-A1 | Novel Cannabinergic Compounds and Uses Thereof | NORTHEASTERN UNIVERSITY (US) | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108016-A1 | Novel Cannabinergic Compounds and Uses Thereof | CNR2, CNR1, GPR18 | IL6ST 1124/4885IDH1 2714/4885STAT3 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.